Clinical Trial Update: Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis [Phase 2]

View source ↗

Summary

Phase 2 study assessing efficacy and safety of Dysport for migraine prophylaxis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Migraine | Phase 2 | Status: COMPLETED